Bioequivalence and generic prescribing: An industrial view

被引:16
作者
Pidgen, A
机构
关键词
D O I
10.1111/j.2042-7158.1996.tb05868.x
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
引用
收藏
页码:11 / 16
页数:6
相关论文
共 12 条
[1]
CONSIDERATION OF INDIVIDUAL BIOEQUIVALENCE [J].
ANDERSON, S ;
HAUCK, WW .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1990, 18 (03) :259-273
[2]
Chow S-C, 1994, DRUG INF J, V28, P851
[3]
DALEYYATES PT, 1994, MEASUREMENT KINETICS
[4]
ENDRENYI L, 1991, INT J CLIN PHARM TH, V29, P394
[5]
HAUCK WW, 1995, BIOINTERNATIONAL, V2
[6]
LACEY LF, 1995, BIOINTERNATIONAL, V2
[7]
STATISTICAL ASPECTS OF BIOEQUIVALENCE - A REVIEW [J].
PIDGEN, AW .
XENOBIOTICA, 1992, 22 (07) :881-893
[8]
Salmonson Tomas, 1995, P195
[9]
A COMPARISON OF THE 2 ONE-SIDED TESTS PROCEDURE AND THE POWER APPROACH FOR ASSESSING THE EQUIVALENCE OF AVERAGE BIOAVAILABILITY [J].
SCHUIRMANN, DJ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1987, 15 (06) :657-680
[10]
TOZER TN, 1995, BIOINTERNATIONAL, V2